Co-expression of δ-secretase-truncated human APP C586-695 fragment and human Tau N368 truncate in the hippocampus of wild-type mice additively drives AD-like pathogenesis and cognitive dysfunctions13, suggesting that δ-secretase activity may promote AD-like pathology onset when both APP and Tau are abundant. The gene discussed is MAPT; the disease is Alzheimer disease.